Posters & Publications


BIO101, a drug candidate targeting Mas Receptor for the treatment of age-related muscle degeneration. From molecular target identification to clinical development. Dilda et al. Poster presentation at the 9th international SCWD conference on cachexia, sarcopenia and muscle wasting, December 10-11, 2016, Berlin, Germany.

Abstract published in Journal of Cachexia, Sarcopenia and Muscle7(5), 655. Abstract 4-01.


A randomized, placebo-controlled trial to evaluate the efficacy and safety of BIO101 on Sarcopenic Obesity. Dioh et al. Poster presentation at the 7th International Conference on Frailty & Sarcopenia Research (ICFSR), April 28-29, 2016, Philadelphia, USA.

Abstract published in The Journal of Frailty & Aging, 5, S1, 75, Abstract P53.